IMNM CIK: 1472012

Immunome Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.2
FY22:
−28.7
FY23:
−7.57
FY24:
−111
FY25:
−191
Change from FY21 to FY25
millions USD
FY21:
−0.08
FY22:
−0.25
FY23:
−30.5
FY24:
−85.1
FY25:
60.8
Change from FY21 to FY25
millions USD
FY21:
27.8
FY22:
0.03
FY23:
116
FY24:
241
FY25:
640
millions USD
FY21:
9.46
FY22:
−28.9
FY23:
78.4
FY24:
44.7
FY25:
510
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.3
FY22:
−28.9
FY23:
−8.40
FY24:
−118
FY25:
−201

All amounts in millions USD Data source:SEC EDGAR